Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Antitrust regulators in India flagged Disney’s $8.5 billion merger with Reliance for competition concerns in cricket broadcast rights.
The European Commission on Tuesday solidified new tariffs for electric vehicles imported from China. The actual numbers aren’t harsh.
GM is cutting over 1,000 workers, equivalent to roughly 1.3% of its total workforce, from its software and services division.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
After nearly 3,000 years, the business of the Olympics is ripe for disruption. Could performance enhancing drugs shake up the games?
The World Health Organization has declared mpox to be a public health emergency, and pharmaceutical and healthcare winners have emerged.
But data aside, many have cast doubt on the company’s plan for autonomous ridesharing.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
For Starbucks chief Laxman Narasimhan, the daily grind is over. The embattled coffee chain named Chipotle CEO Brian Niccol his successor.
As Paramount moves under the control of Skydance Media, current leadership is undergoing a campaign to realize half a billion in savings.
Airbus hasn’t been able to capitalize much on Boeing’s misfortunes thanks to its own workforce and supply chain issues.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.